RESUMEN

Accurate hydrological data with high spatial resolution is important for flood risk and water resource management, particularly under the context of climate change. The cost of monitoring networks, as well as the characteristics of the hydrological environment itself, can be a barrier to meeting these data requirements, however. This study covers the design and testing of a low-cost, "build-it-yourself", instream water depth sensor providing an assessment of its potential in future hydrological monitoring projects. The low-cost sensor was built using an Arduino microcontroller, a differential pressure sensor and a thermistor, a real-time clock, and an SD card module. The low-cost logger was deployed in tandem with a factory-calibrated Solinst®LevelLogger® 5 Junior for 6 months in the River Wissey, UK. We found the mean absolute error of the Arduino-based logger relative to the commercial setup to be ±0.69 cm for water depth and ±0.415 °C for water temperature. Economically, the Arduino-based logger offers an advantage, costing a total of £133.35 (USD 168.26 at time of publication) comparative to the industrial comparison's cost of £408 (USD 514.83 at time of publication). This study concludes that the low cost of the Arduino-based logger gives a strong advantage to its incorporation in hydrological data collection, if the trade-offs (i.e., time investment and accuracy) are considered acceptable and appropriate for a project.

RESUMEN

AIMS: Hemangioblastomas may arise sporadically or in the setting of Von Hippel-Lindau (VHL) disease. In either instance, it rarely occurs outside the central nervous system. By analysis of a large case series, we sought to further characterize the clinical, radiologic and pathologic features of hemangioblastomas involving nerve root. MATERIALS AND METHODS: The clinical resentations of 6 proximal nerve root hemangioblastomas (1 an aggressive tumor) were analyzed with emphasis on the neuroimaging, operative, and pathologic findings. The literature is fully reviewed and updated. RESULTS: Nerve hemangioblastoma usually affects proximal spinal roots. Peripheral nerve is rarely involved. Both clinically and radiologically, the diagnosis is usually not suspected before surgery. Profuse bleeding at resection may be the first indication of the nature of the lesion. These tumors may arise both sporadically and in association with VHL disease. CONCLUSION: Given their rarity, nerve root hemangioblastomas are not generally considered in the preoperative differential diagnosis of proximal nerve root lesions. Given their propensity to bleed profusely at surgery and the potential association with VHL disease, knowledge of this entity is important.

Asunto(s)

RESUMEN

BACKGROUND: There is limited epidemiologic data on patients with acute myelogenous (myeloid) leukemia (AML) requiring life-sustaining therapies in the intensive care unit (ICU). Our objectives were to describe the clinical characteristics and outcomes in critically ill AML patients. METHODS: This was a retrospective case-control study. Cases were defined as adult patients with a primary diagnosis of AML admitted to ICU at the University of Alberta Hospital between January 1st 2002 and June 30th 2008. Each case was matched by age, sex, and illness severity (ICU only) to two control groups: hospitalized AML controls, and non-AML ICU controls. Data were extracted on demographics, course of hospitalization, and clinical outcomes. RESULTS: In total, 45 AML patients with available data were admitted to ICU. Mean (SD) age was 54.8 (13.1) years and 28.9% were female. Primary diagnoses were sepsis (32.6%) and respiratory failure (37.3%). Mean (SD) APACHE II score was 30.3 (10.3), SOFA score 12.6 (4.0) with 62.2% receiving mechanical ventilation, 55.6% vasoactive therapy, and 26.7% renal replacement therapy. Crude in-hospital, 90-day and 1-year mortality was 44.4%, 51.1% and 71.1%, respectively. AML cases had significantly higher adjusted-hazards of death (HR 2.23; 95% CI, 1.38-3.60, p = 0.001) compared to both non-AML ICU controls (HR 1.69; 95% CI, 1.11-2.58, p = 0.02) and hospitalized AML controls (OR 1.0, reference variable). Factors associated with ICU mortality by univariate analysis included older age, AML subtype, higher baseline SOFA score, no change or an increase in early SOFA score, shock, vasoactive therapy and mechanical ventilation. Active chemotherapy in ICU was associated with lower mortality. CONCLUSIONS: AML patients may represent a minority of all critically ill admissions; however, are not uncommonly supported in ICU. These AML patients are characterized by high illness severity, multi-organ dysfunction, and high treatment intensity and have a higher risk of death when compared with matched hospitalized AML or non-AML ICU controls. The absence of early improvement in organ failure may be a useful predictor for mortality for AML patients admitted to ICU.

Asunto(s)

Asunto(s)